Literature DB >> 26179303

Challenges in Preparation of Cumulative Antibiogram Reports for Community Hospitals.

Rebekah W Moehring1, Kevin C Hazen2, Myra R Hawkins3, Richard H Drew4, Daniel J Sexton5, Deverick J Anderson5.   

Abstract

Knowledge of local antimicrobial resistance is critical for management of infectious diseases. Community hospitals' compliance with Clinical and Laboratory Standards Institute (CLSI) guidance for creation of cumulative antibiograms is uncertain. This descriptive cohort study of antibiogram reporting practices included community hospitals enrolled in the Duke Infection Control Outreach Network. Cumulative antibiograms from 2012 were reviewed for criteria on reporting practices and compliance with CLSI guidelines. Microbiology personnel were sent a voluntary, electronic survey on antibiogram preparation practices. Data were compiled using descriptive statistics. Thirty-two of 37 (86%) hospitals provided antibiograms; 26 of 37 (70%) also provided survey responses. Twelve (38%) antibiograms specified methods used for compiling data and exclusion of duplicates. Eight (25%) reported only species with >30 isolates. Of the 24 that did not follow the 30-isolate rule, 3 (13%) included footnotes to indicate impaired statistical validity. Twenty (63%) reported at least 1 pathogen-drug combination not recommended for primary or supplemental testing per CLSI. Thirteen (41%) separately reported methicillin-resistant and -susceptible Staphylococcus aureus. Complete compliance with CLSI guidelines was observed in only 3 (9%) antibiograms. Survey respondents' self-assessment of full or partial compliance with CLSI guidelines was 50% and 15%, respectively; 33% reported uncertainty with CLSI guidelines. Full adherence to CLSI guidelines for hospital antibiograms was uncommon. Uncertainty about CLSI guidelines was common. Alternate strategies, such as regional antibiograms using pooled data and educational outreach efforts, are needed to provide reliable and appropriate susceptibility estimates for community hospitals.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26179303      PMCID: PMC4540907          DOI: 10.1128/JCM.01077-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Are United States hospitals following national guidelines for the analysis and presentation of cumulative antimicrobial susceptibility data?

Authors:  Erika J Ernst; Daniel J Diekema; Bonnie J BootsMiller; Thomas Vaughn; Jon W Yankey; Stephen D Flach; Marcia M Ward; Carrie L J Franciscus; Elise Acosta; Michael A Pfaller; Bradley N Doebbeling
Journal:  Diagn Microbiol Infect Dis       Date:  2004-06       Impact factor: 2.803

2.  Antibiogram compliance in University HealthSystem Consortium participating hospitals with Clinical and Laboratory Standards Institute guidelines.

Authors:  Ran Xu; Ronald E Polk; Lynda Stencel; Denise K Lowe; Roy Guharoy; Raj W Duggal; Michelle Wiest; Kimberly S Putney; Nora B Flint
Journal:  Am J Health Syst Pharm       Date:  2012-04-01       Impact factor: 2.637

3.  Systematic review of antibiograms: A National Laboratory System approach for improving antimicrobial susceptibility testing practices in Michigan.

Authors:  Martha S Boehme; Patricia A Somsel; Frances Pouch Downes
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

4.  Nationwide antibiogram analysis using NCCLS M39-A guidelines.

Authors:  Antonia Zapantis; Melinda K Lacy; Rebecca T Horvat; Dennis Grauer; Brian J Barnes; Brian O'Neal; Rick Couldry
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

5.  Analysis and presentation of cumulative antimicrobial susceptibility data (antibiograms): substantial variability across medical centers in the United States.

Authors:  Ebbing Lautenbach; Irving Nachamkin
Journal:  Infect Control Hosp Epidemiol       Date:  2006-03-17       Impact factor: 3.254

Review 6.  Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute.

Authors:  Janet F Hindler; John Stelling
Journal:  Clin Infect Dis       Date:  2007-02-08       Impact factor: 9.079

7.  Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program.

Authors:  Harold C Standiford; Shannon Chan; Megan Tripoli; Elizabeth Weekes; Graeme N Forrest
Journal:  Infect Control Hosp Epidemiol       Date:  2012-04       Impact factor: 3.254

8.  The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network.

Authors:  Deverick J Anderson; Becky A Miller; Luke F Chen; Linda H Adcock; Evelyn Cook; A Lynn Cromer; Susan Louis; Paul A Thacker; Daniel J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

9.  The future of antibiotics and resistance.

Authors:  Brad Spellberg; John G Bartlett; David N Gilbert
Journal:  N Engl J Med       Date:  2013-01-24       Impact factor: 91.245

  9 in total
  14 in total

Review 1.  Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship.

Authors:  Philippe Morency-Potvin; David N Schwartz; Robert A Weinstein
Journal:  Clin Microbiol Rev       Date:  2016-12-14       Impact factor: 26.132

Review 2.  Antifungal stewardship considerations for adults and pediatrics.

Authors:  Rana F Hamdy; Theoklis E Zaoutis; Susan K Seo
Journal:  Virulence       Date:  2016-09-02       Impact factor: 5.882

3.  Curbing antimicrobial resistance: Do physicians receive adequate education about antibiograms?

Authors:  Priyasheelta Nand; Machelle D Wilson; Stuart H Cohen; Jennifer Brown
Journal:  J Infect       Date:  2015-10-09       Impact factor: 6.072

4.  Antimicrobial Stewardship in Long-Term Care Facilities: Approaches to Creating an Antibiogram when Few Bacterial Isolates Are Cultured Annually.

Authors:  Maria-Stephanie A Tolg; David M Dosa; Robin L P Jump; Angelike P Liappis; Kerry L LaPlante
Journal:  J Am Med Dir Assoc       Date:  2018-06-19       Impact factor: 4.669

Review 5.  Diagnostic Bacteriology in District Hospitals in Sub-Saharan Africa: At the Forefront of the Containment of Antimicrobial Resistance.

Authors:  Jan Jacobs; Liselotte Hardy; Makeda Semret; Octavie Lunguya; Thong Phe; Dissou Affolabi; Cedric Yansouni; Olivier Vandenberg
Journal:  Front Med (Lausanne)       Date:  2019-09-23

6.  Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against Pseudomonas aeruginosa From ICU Patients With Bloodstream Infections or Pneumonia.

Authors:  Dee Shortridge; Michael A Pfaller; S J Ryan Arends; Janet Raddatz; Daryl D DePestel; Robert K Flamm
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

Review 7.  The antibiogram: key considerations for its development and utilization.

Authors:  William R Truong; Levita Hidayat; Michael A Bolaris; Lee Nguyen; Jason Yamaki
Journal:  JAC Antimicrob Resist       Date:  2021-05-25

8.  Antibiogram Development in the Setting of a High Frequency of Multi-Drug Resistant Organisms at University Teaching Hospital, Lusaka, Zambia.

Authors:  Brenna M Roth; Alexandra Laps; Kaunda Yamba; Emily L Heil; J Kristie Johnson; Kristen Stafford; Lottie M Hachaambwa; Mox Kalumbi; Lloyd Mulenga; Devang M Patel; Cassidy W Claassen
Journal:  Antibiotics (Basel)       Date:  2021-06-28

9.  Comparative Epidemiology and Resistance Trends of Proteae in Urinary Tract Infections of Inpatients and Outpatients: A 10-Year Retrospective Study.

Authors:  Márió Gajdács; Edit Urbán
Journal:  Antibiotics (Basel)       Date:  2019-07-11

10.  Can surgical site infections be controlled through microbiological surveillance? A three-year laboratory-based surveillance at an orthopaedic unit, retrospective observatory study.

Authors:  Iwona Pawłowska; Grzegorz Ziółkowski; Jadwiga Wójkowska-Mach; Tomasz Bielecki
Journal:  Int Orthop       Date:  2019-01-24       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.